Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Stocks in the Red Today?

Page 1 of 2

After opening flat, the three indexes have sold off again. The Dow, S&P and NASDAQ are each off around 0.6%, while crude futures are down twice as much to hover just above $48 per barrel. Among the stocks also in the red are Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC), NXP Semiconductors NV (NASDAQ:NXPI), Staples, Inc. (NASDAQ:SPLS), and Synchrony Financial (NYSE:SYF). Let’s find out why traders are selling and see how elite funds think of each stock.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see the details here).

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

RAJ CREATIONZS / shutterstock.com

Infinity Pharmaceuticals Falls on Study Results

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) is 70% lower today after a Phase 2 trial showed that the company’s investigational molecule Duvelisib failed to impress despite meeting the primary endpoint of overall response rate. Because the drug did not yield a larger clinical benefit for patients with advanced indolent non-Hodgkin lymphoma, Infinity and AbbVie Inc (NYSE:ABBV) agreed to pause a Phase 1b/2 study evaluating duvelisib in combination with venetoclax. The company will seek feedback from the FDA on its next steps and is undertaking a strategic restructuring by closing down its discovery research organization which will impact 46 people. A total of 16 funds from our database were long Infinity Pharmaceuticals Inc. (NASDAQ:INFI) at the end of the first quarter, unchanged from the previous quarter.

Follow Infinity Pharmaceuticals Inc. (NASDAQ:INFI)
Trade (NASDAQ:INFI) Now!

Ericsson Cuts Costs

Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) shares are off by 1.4% after the company announced it will lay off 3,000 to 4,000 of its workforce this summer. Given that much of latest generation networks have been built, the company has had a hard time growing its revenue. The sluggish growth has put pressure on management to cut costs. The company is also considering additional cost cutting measures too. The number of funds  tracked by Insider Monkey with holdings in Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) rose by seven to 13 during the first quarter of 2016.

Follow Ericsson L M Telephone Co (NASDAQ:ERIC)
Trade (NASDAQ:ERIC) Now!

On the next page, we examine NXP Semiconductors, Staples, and Synchrony Financial.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!